Scribe logoScribeNotes & practice
Sign inStart free
  1. Notes
  2. ›Edexcel A-level Biology A (Salters-Nuffield)
  3. ›8 Grey Matter
  4. ›8.14 Brain chemical imbalances

Edexcel A-level Biology A (Salters-Nuffield) · Topic 8 · Grey Matter

8.14 Brain chemical imbalances

Explain how brain chemical imbalances affect behaviour, describe linked disorders and outline how treatments correct them.

  • 4 min read
  • 5 parts
  • 10 questions
  • Draft
Start a Quick 5 on this topic→Jump to the 10 questions
1/5Neurotransmitter levels set how strongly synapses pass signals
  1. 1Neurotransmitter levels set how strongly synapses pass signals
  2. 2Loss of dopamine neurones causes the symptoms of Parkinson’s disease
  3. 3Imbalances in other transmitters are linked to mood and thought
  4. 4Drugs can raise transmitter levels or block receptors
  5. 5Treatments ease symptoms but rarely cure the underlying disorder
  6. Check your recall
  7. Practice: 10 questions
1

Part 1 of 5: Neurotransmitter levels set how strongly synapses pass signals

Think of a synapse as a messaging system. A neurotransmitter is released, crosses the gap and binds to a receptor protein on the next cell. The gap is called the synaptic cleft.

The size of the signal depends on how much transmitter is available and how many receptors respond. It also depends on how quickly transmitter is removed from the cleft. Changing any of these changes the signal.

Different brain regions rely on different transmitters. A shortage or excess can therefore alter movement, mood or perception.

Common mistake

No behaviour is controlled by a single chemical. Many transmitters and brain regions act together.

Key terms · tap one for its definition

neurotransmitter

A neurotransmitter is a chemical released at a synapse that binds to receptors on the receiving cell.

receptor protein

A receptor protein is a membrane protein with a binding site that fits a specific neurotransmitter.

Part 1 done

2

Part 2 of 5: Loss of dopamine neurones causes the symptoms of Parkinson’s disease

A clear example of an imbalance is Parkinson’s disease. Some neurones release dopamine, a neurotransmitter that helps control voluntary movement. In Parkinson’s disease, many of these neurones gradually die.

Less dopamine is released at synapses in movement pathways. The signals that start and smooth movement become weaker.

People develop tremor, stiff muscles and slow movement. Because the loss is progressive, the dopamine shortage increases over time. The cause of the neurone loss is not fully understood. The disease usually appears later in life, and movement becomes harder to start and to control.

Key terms · tap one for its definition

dopamine

Dopamine is a neurotransmitter released by neurones in pathways that control movement, reward and some aspects of mood.

Parkinson’s disease

Parkinson’s disease is a progressive disorder caused by the loss of dopamine-releasing neurones, producing tremor, slow movement and muscle stiffness.

Part 2 done

Quick check

One question on the part you just read

Easy

Identify the best definition of a neurotransmitter.
Show answer and explanation

Answer: B · Worked explanation

A neurotransmitter is a chemical released at a synapse that binds to receptors on the receiving cell. An electrical signal is an impulse, and a hormone travels in the blood. The protein that moves transmitter back into the sending neurone is a transporter, not the transmitter itself.
3

Part 3 of 5: Imbalances in other transmitters are linked to mood and thought

Other transmitters are linked to mental health disorders. In depression, low activity at synapses that use serotonin is associated with low mood. Serotonin is also involved in sleep and appetite. In schizophrenia, overactive dopamine pathways are linked to hallucinations.

Neurotransmitter changes linked to three disorders

DisorderTransmitterChange linked to symptoms
Parkinson’s diseaseDopamineToo little in movement pathways
DepressionSerotoninLow activity at some synapses
SchizophreniaDopamineOveractivity in some pathways
Disorder
Parkinson’s disease
Transmitter
Dopamine
Change linked to symptoms
Too little in movement pathways
Disorder
Depression
Transmitter
Serotonin
Change linked to symptoms
Low activity at some synapses
Disorder
Schizophrenia
Transmitter
Dopamine
Change linked to symptoms
Overactivity in some pathways

Depression involves persistent low mood and loss of interest. Schizophrenia can involve hallucinations and disordered thinking. Both disorders vary widely between people. These links are associations, not complete explanations. Genes, development and experience also influence each disorder. Researchers still debate how large a part each chemical plays.

Key terms · tap one for its definition

serotonin

Serotonin is a neurotransmitter involved in regulating mood, sleep and appetite.

schizophrenia

Schizophrenia is a disorder with symptoms such as hallucinations and disordered thinking, linked to overactivity of some dopamine pathways.

Part 3 done

4

Part 4 of 5: Drugs can raise transmitter levels or block receptors

Treatments aim to move transmitter activity back towards normal. Different drugs act at different steps of synaptic transmission.

  • In Parkinson’s disease, L-dopa is converted to dopamine in the brain.
  • In depression, some drugs block the reuptake of serotonin.
  • In schizophrenia, some drugs block dopamine receptor proteins.
Figure 1. Neurotransmitter crosses the gap and binds receptor proteins. Transporters in the sending neurone’s membrane take it back up, shown by the arrow.

Normally, transporters take serotonin back into the sending neurone. Blocking this step leaves more serotonin in the cleft. Dopamine receptor blockers reduce the effect of dopamine on the receiving cell.

Exam tip

Name the drug action, the transmitter and the change it causes. “Blocks reuptake of serotonin” earns more than “increases serotonin”.

Key term

reuptake

Reuptake is the process by which transporter proteins take neurotransmitter back into the sending neurone, ending its action at the synapse.

Part 4 done

Quick check

One question on the part you just read

Easy

Identify the neurotransmitter whose loss is linked to Parkinson’s disease.
Show answer and explanation

Answer: A · Worked explanation

Parkinson’s disease involves the loss of neurones that release dopamine in movement pathways. Serotonin is linked to mood and is a tempting wrong answer, but it is not the transmitter lost in Parkinson’s disease. Insulin and thyroxine are hormones, not neurotransmitters.
5

Part 5 of 5: Treatments ease symptoms but rarely cure the underlying disorder

Drugs correct the chemical imbalance, not always its cause. L-dopa does not stop dopamine neurones dying, so symptoms return as the disease advances.

Transmitters work throughout the brain, so drugs can cause side effects. Dopamine-raising drugs, for example, can sometimes cause hallucinations.

Common mistake

A treatment that restores a chemical level is not a cure. Neurone loss or other causes may continue.

Responses also vary between people. Drugs that raise serotonin levels often take weeks to relieve depression, which suggests that other changes are involved. Doctors therefore monitor each patient and adjust the dose.

Note read

Check your recall[13 marks]

5 written questions. Answer each one in your head or on paper, then open the mark scheme.

  1. 1.Explain[3 marks]

    Explain how a loss of dopamine neurones causes the symptoms of Parkinson’s disease.

    Show mark schemeHide mark scheme

    Model answer

    The neurones that release dopamine in movement pathways die. Less dopamine is released at their synapses, so signals controlling movement are weaker. This produces tremor, stiffness and slow movement.

    • 1 mark for stating that dopamine-releasing neurones die
    • 1 mark for stating that less dopamine is released at synapses in movement pathways
    • 1 mark for linking weaker signals to tremor, stiffness or slow movement
  2. 2.Describe[3 marks]

    Describe how a drug that blocks serotonin reuptake can reduce the symptoms of depression.

    Show mark schemeHide mark scheme

    Model answer

    The drug blocks the transporters that take serotonin back into the sending neurone. Serotonin stays in the cleft for longer. Receptors on the receiving cell are stimulated more.

    • 1 mark for stating that the drug blocks the transporters that take up serotonin
    • 1 mark for stating that serotonin stays in the cleft for longer
    • 1 mark for stating that receptors on the receiving cell are stimulated more
  3. 3.Outline[2 marks]

    Outline how drugs that block dopamine receptor proteins can reduce the symptoms of schizophrenia.

    Show mark schemeHide mark scheme

    Model answer

    Overactive dopamine pathways are linked to symptoms such as hallucinations. Blocking the receptor proteins reduces the effect of dopamine on the receiving cell.

    • 1 mark for linking overactive dopamine pathways to symptoms
    • 1 mark for stating that blocking receptor proteins reduces the effect of dopamine
  4. 4.Suggest[3 marks]

    Suggest why drug treatment for Parkinson’s disease eases symptoms but does not cure the disease.

    Show mark schemeHide mark scheme

    Model answer

    L-dopa is converted to dopamine, which makes up for the shortage. It does not stop the dopamine-releasing neurones from dying. Symptoms therefore return as the disease advances.

    • 1 mark for stating that the drug restores dopamine levels
    • 1 mark for stating that it does not stop neurones dying
    • 1 mark for stating that symptoms return or worsen as the disease advances
  5. 5.Give[2 marks]

    Give two ways in which the strength of a signal across a synapse could be changed.

    Show mark schemeHide mark scheme

    Model answer

    Change the amount of neurotransmitter released. Change the number of receptor proteins, or change how quickly transmitter is removed by reuptake.

    • 1 mark for giving a change in the amount of neurotransmitter released
    • 1 mark for giving a change in receptor numbers or in the rate of removal

Practice this topic

10 quick-fire multiple-choice questions, easy to hard. Tap an answer to see if you're right and the worked explanation. (The written questions with mark schemes are under “Check your recall” above.)

0 right0 of 10 answered

Includes the 2 quick checks in the note above.

3.

Easy·State[1 mark]

State the effect of reuptake at a synapse.
Show answer and explanation

Answer: C · Worked explanation

Reuptake takes neurotransmitter back into the sending neurone, so it is no longer in the cleft and its action ends. Release from vesicles is the opposite step. Reuptake does not make receptor proteins or carry transmitter along the axon, because it only returns transmitter to the neurone that released it.
4.

Medium·Predict[2 marks]

A drug blocks the transporters that take serotonin back into the sending neurone. Predict the effect.
Show answer and explanation

Answer: D · Worked explanation

Blocking reuptake slows removal, so serotonin remains in the cleft and keeps stimulating receptors. Faster removal would be the opposite effect. The drug acts on the transporters, not on release from the sending neurone or on the receptors. Destroying receptors would stop the signal rather than prolong it.
5.

Medium·Calculate[2 marks]

A measurement gives dopamine release as 40 arbitrary units in a healthy volunteer and 14 arbitrary units in a person with Parkinson’s disease. Calculate the percentage reduction in the person with the disease.
Show answer and explanation

Answer: B · Worked explanation

The reduction is 40 − 14 = 26 units. As a percentage this is 2640×100=65\frac{26}{40}\times100=654026​×100=65. The value 35% is the person’s release as a percentage of the healthy value, and 26 is the change in units, not a percentage. The value 286% comes from dividing the healthy value by the reduced value.
6.

Medium·Identify[2 marks]

Identify the treatment that is matched correctly with its disorder and its action.
Show answer and explanation

Answer: A · Worked explanation

L-dopa is converted to dopamine, which makes up for the shortage in Parkinson’s disease. It does not block receptors, so it is not a treatment for schizophrenia. Reuptake blockers keep transmitter in the cleft rather than destroying it, and receptor blockers act on dopamine, not serotonin levels.
7.

Medium·Predict[2 marks]

A sending neurone releases normal amounts of neurotransmitter, but the receiving cell has fewer receptor proteins. Predict the effect on the signal.
Show answer and explanation

Answer: C · Worked explanation

The strength of a signal depends on receptors as well as on release. With fewer receptor proteins, less transmitter binds and the response in the receiving cell is weaker. Normal release does not guarantee a normal signal, and fewer receptors do not stop reuptake.
8.

Hard·Explain[2 marks]

Some people with Parkinson’s disease who take a dopamine-raising drug develop hallucinations. Explain the best-supported reason.
Show answer and explanation

Answer: B · Worked explanation

Dopamine acts in many pathways, and overactivity in some of them is linked to hallucinations, as in schizophrenia. The drug raises dopamine, so it cannot be lowering it. It does not destroy neurones or block serotonin reuptake. Blocking reuptake would affect serotonin, which is not the transmitter that the drug raises in this case.
9.

Hard·Predict[2 marks]

A patient takes a drug that blocks serotonin reuptake. Serotonin in the cleft rises within hours, but mood improves only after weeks. Predict the most reasonable interpretation.
Show answer and explanation

Answer: D · Worked explanation

A quick rise in serotonin with a slow improvement suggests serotonin is part of the picture while slower changes also matter. It does not show that serotonin plays no part. The delay does not mean the drug has failed, and it does not show that reuptake is the only cause.
10.

Hard[2 marks]

Which statement about neurotransmitter imbalances is correct?
Show answer and explanation

Answer: B · Worked explanation

Behaviour depends on many transmitters and brain regions, and genes, development and experience also contribute, so imbalances are associations rather than complete explanations. Correcting one level does not guarantee a cure. Causes vary between people, and responses to drugs differ and can take weeks.

Keep going

Next topic8.15 Drugs and synaptic transmissionPrevious topic8.13 Habituation

More in Topic 8 · Grey Matter

  1. 8.10Critical periods in developmentNotes · 10 questions
  2. 8.11Animal models in researchNotes · 10 questions
  3. 8.12Ethics of animal researchNotes · 10 questions
  4. 8.13HabituationNotes · 10 questions
  5. 8.14Brain chemical imbalancesNotes · 10 questions
  6. 8.15Drugs and synaptic transmissionNotes · 10 questions
  7. 8.16Genome sequencing and personalised medicineNotes · 10 questions
  8. 8.17Drugs from genetically modified organismsNotes · 10 questions
  9. 8.18Risks and benefits of GMOsNotes · 10 questions

All Edexcel A-level Biology A (Salters-Nuffield) topics →

Draft: written by Scribe and checked automatically, not yet by a subject reviewer.

Practice questions are original, written by Scribe and checked automatically for correctness.

Topic codes follow the official numbering. Not endorsed by Pearson Edexcel or any exam board.

On this page

0/5 read

  1. 1Neurotransmitter levels set how strongly synapses pass signals
  2. 2Loss of dopamine neurones causes the symptoms of Parkinson’s disease
  3. 3Imbalances in other transmitters are linked to mood and thought
  4. 4Drugs can raise transmitter levels or block receptors
  5. 5Treatments ease symptoms but rarely cure the underlying disorder
  6. Check your recall
  7. Practice: 10 questions
All coursesScribeHow it worksPricingPrivacyTerms

Notes and questions are written by Scribe in our own words. Topic codes follow the official course numbering so you can find your place. Not produced or endorsed by the IB, College Board, AQA, OCR, Pearson Edexcel or any exam board.

© 2026 Scribe